Trial Condition(s):

Cystic Fibrosis

Pilot study to compare acarbose (BAY g 5421) with placebo in respect of efficacy and tolerability in patients with cystic fibrosis and pathological glucose tolerance

Bayer Identifier:

Trial_0696

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
12
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Acarbose (Precose/Glucobay, BAYG5421)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information